Src family kinases mediate epidermal growth factor receptor signaling from lipid rafts in breast cancer cells

Por Irwin, Mary E, Bohin, Natacha, Boerner, Julie L
Publicado em 2011

Phosphorylation of Y845 on the Epidermal Growth Factor Receptor Mediates Binding to the Mitochondrial Protein Cytochrome c Oxidase Subunit II

Por Boerner, Julie L., Demory, Michelle L., Silva, Corinne, Parsons, Sarah J.
Publicado em 2004

Met and c-Src Cooperate to Compensate for Loss of Epidermal Growth Factor Receptor Kinase Activity in Breast Cancer Cells

Por Mueller, Kelly L., Hunter, Lauren A., Ethier, Stephen P., Boerner, Julie L.
Publicado em 2008

Lipid raft localization of EGFR alters the response of cancer cells to the EGFR tyrosine kinase inhibitor gefitinib

Por Irwin, Mary E., Mueller, Kelly L., Bohin, Natacha, Ge, Yubin, Boerner, Julie L.
Publicado em 2011

EGFR Tyrosine 845 Phosphorylation-Dependent Proliferation and Transformation of Breast Cancer Cells Require Activation of p38 MAPK

Por Mueller, Kelly L, Powell, Katelyn, Madden, Julie M, Eblen, Scott T, Boerner, Julie L
Publicado em 2012

EGFR/Met association regulates EGFR TKI resistance in breast cancer

Por Mueller, Kelly L, Yang, Zeng-Quan, Haddad, Ramsi, Ethier, Stephen P, Boerner, Julie L
Publicado em 2010

Genomic amplification and a role in drug-resistance for the KDM5A histone demethylase in breast cancer

Por Hou, Jinling, Wu, Jack, Dombkowski, Alan, Zhang, Kezhong, Holowatyj, Andreana, Boerner, Julie L, Yang, Zeng-Quan
Publicado em 2012

Fibroblast-secreted hepatocyte growth factor mediates epidermal growth factor receptor tyrosine kinase inhibitor resistance in triple-negative breast cancers through paracrine acti...

Por Mueller, Kelly L, Madden, Julie M, Zoratti, Gina L, Kuperwasser, Charlotte, List, Karin, Boerner, Julie L
Publicado em 2012

Regulation of the Src-PP2A Interaction in Tumor Necrosis Factor (TNF)-related Apoptosis-inducing Ligand (TRAIL)-induced Apoptosis

Por Xu, Jing, Xu, Zhengfan, Zhou, Jun-Ying, Zhuang, Zhengping, Wang, Enhua, Boerner, Julie, Wu, Gen Sheng
Publicado em 2013

Abrogating phosphorylation of eIF4B is required for EGFR and mTOR inhibitor synergy in triple-negative breast cancer

Por Madden, Julie M, Mueller, Kelly L, Bollig-Fischer, Aliccia, Stemmer, Paul, Mattingly, Raymond R, Boerner, Julie L
Publicado em 2014

A targeted enzyme approach to sensitization of tyrosine kinase inhibitor-resistant breast cancer cells

Por Giordano, Courtney R., Mueller, Kelly L., Terlecky, Laura J., Krentz, Kendra A., Bollig-Fischer, Aliccia, Terlecky, Stanley R., Boerner, Julie L.
Publicado em 2012

Epidermal Growth Factor Receptor Translocation to the Mitochondria: REGULATION AND EFFECT

Por Demory, Michelle L., Boerner, Julie L., Davidson, Robert, Faust, William, Miyake, Tsuyoshi, Lee, Icksoo, Hüttemann, Maik, Douglas, Robert, Haddad, Gabriel, Parsons, Sarah J.
Publicado em 2009

RUNX1 regulates phosphoinositide 3-kinase/AKT pathway: role in chemotherapy sensitivity in acute megakaryocytic leukemia

Por Edwards, Holly, Xie, Chengzhi, LaFiura, Katherine M., Dombkowski, Alan A., Buck, Steven A., Boerner, Julie L., Taub, Jeffrey W., Matherly, Larry H., Ge, Yubin
Publicado em 2009

Protein Expression of DNA Damage Repair Proteins Dictates Response to Topoisomerase and PARP Inhibitors in Triple-Negative Breast Cancer

Por Boerner, Julie L., Nechiporchik, Nicole, Mueller, Kelly L., Polin, Lisa, Heilbrun, Lance, Boerner, Scott A., Zoratti, Gina L., Stark, Karri, LoRusso, Patricia M., Burger, Angelika
Publicado no PLoS One (2015)

Treating triple negative breast cancer cells with erlotinib plus a select antioxidant overcomes drug resistance by targeting cancer cell heterogeneity

Por Bao, Bin, Mitrea, Cristina, Wijesinghe, Priyanga, Marchetti, Luca, Girsch, Emily, Farr, Rebecca L., Boerner, Julie L, Mohammad, Ramzi, Dyson, Greg, Terlecky, Stanley R., Bollig-Fischer, Aliccia
Publicado no Sci Rep (2017)

Targeting matriptase in breast cancer abrogates tumor progression via impairment of stromal-epithelial growth factor signaling

Por Zoratti, Gina L., Tanabe, Lauren M., Varela, Fausto A., Murray, Andrew S., Bergum, Christopher, Colombo, Eloic, Lang, Julie, Molinolo, Alfredo A., Leduc, Richard, Marsault, Eric, Boerner, Julie, List, Karin
Publicado no Nat Commun (2015)

Matriptase regulates c-Met mediated proliferation and invasion in inflammatory breast cancer

Por Zoratti, Gina L., Tanabe, Lauren M., Hyland, Thomas E., Duhaime, Michael J., Colombo, Éloïc, Leduc, Richard, Marsault, Eric, Johnson, Michael D., Lin, Chen-Yong, Boerner, Julie, Lang, Julie E., List, Karin
Publicado no Oncotarget (2016)

Targeting MET and EGFR crosstalk signaling in triple-negative breast cancers

Por Linklater, Erik S., Tovar, Elizabeth A., Essenburg, Curt J., Turner, Lisa, Madaj, Zachary, Winn, Mary E., Melnik, Marianne K., Korkaya, Hasan, Maroun, Christiane R., Christensen, James G., Steensma, Matthew R., Boerner, Julie L., Graveel, Carrie R.
Publicado no Oncotarget (2016)

Phase I safety, pharmacokinetic and pharmacodynamic study of the poly (ADP-ribose) polymerase (PARP) inhibitor veliparib (ABT-888) in combination with irinotecan in patients with a...

Por LoRusso, Patricia M., Li, Jing, Burger, Angelika, Heilbrun, Lance K., Sausville, Edward A., Boerner, Scott A., Smith, Daryn, Pilat, Mary Jo, Zhang, Jie, Tolaney, Sara M., Cleary, James M., Chen, Alice P., Rubinstein, Lawrence, Boerner, Julie L., Bowditch, Adam, Cai, Dongpo, Bell, Tracy, Wolanski, Andrew, Marrero, Allison M., Zhang, Yiping, Ji, Jiuping, Ferry-Galow, Katherine, Kinders, Robert J., Parchment, Ralph E., Shapiro, Geoffrey I.
Publicado no Clin Cancer Res (2016)